Laboratory for Stem Cell Therapy, Faculty of Medicine, Tsukuba University, Tsukuba 305-8577, Japan; Division of Stem Cell Biology, Center for Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Division of Stem Cell Biology, Center for Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Cell Stem Cell. 2023 Jul 6;30(7):987-1000.e8. doi: 10.1016/j.stem.2023.06.002. Epub 2023 Jun 28.
Gene editing using engineered nucleases frequently produces unintended genetic lesions in hematopoietic stem cells (HSCs). Gene-edited HSC cultures thus contain heterogeneous populations, the majority of which either do not carry the desired edit or harbor unwanted mutations. In consequence, transplanting edited HSCs carries the risks of suboptimal efficiency and of unwanted mutations in the graft. Here, we present an approach for expanding gene-edited HSCs at clonal density, allowing for genetic profiling of individual clones before transplantation. We achieved this by developing a defined, polymer-based expansion system and identifying long-term expanding clones within the CD201CD150CD48c-KitSca-1Lin population of precultured HSCs. Using the Prkdc immunodeficiency model, we demonstrate that we can expand and profile edited HSC clones to check for desired and unintended modifications, including large deletions. Transplantation of Prkdc-corrected HSCs rescued the immunodeficient phenotype. Our ex vivo manipulation platform establishes a paradigm to control genetic heterogeneity in HSC gene editing and therapy.
利用工程化核酸酶进行基因编辑经常会在造血干细胞(HSCs)中产生非预期的遗传损伤。因此,经过基因编辑的 HSC 培养物包含异质群体,其中大多数既不携带所需的编辑,也不携带不需要的突变。因此,移植编辑后的 HSC 存在效率不理想和移植物中出现不需要的突变的风险。在这里,我们提出了一种在克隆密度下扩展基因编辑 HSC 的方法,允许在移植前对单个克隆进行基因分析。我们通过开发一种基于聚合物的定义扩展系统并在预先培养的 HSC 的 CD201CD150CD48c-KitSca-1Lin 群体中鉴定长期扩增克隆来实现这一目标。使用 Prkdc 免疫缺陷模型,我们证明我们可以扩展和分析编辑后的 HSC 克隆,以检查所需和意外的修饰,包括大片段缺失。移植 Prkdc 校正的 HSCs 挽救了免疫缺陷表型。我们的体外操作平台建立了一种控制 HSC 基因编辑和治疗中遗传异质性的范例。